Protherics PLC Block Listing Six Monthly Return 6% Unsecured Convertible Loan Notes London, UK; Brentwood, TN, US: 8 August 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, in accordance with Listing Rule 3.5.6, notifies the following details in respect of a block listing for the Company's 6% Unsecured Convertible Loan Notes: Name of applicant: Protherics PLC Name of scheme: Block Listing in respect of 6% Unsecured Convertible Loan Notes Period of return: From: 9 February 2008 To: 8 August 2008 Balance of unallotted 8,430,060 Ordinary Shares (Loan securities under scheme from Notes to the value of GBP2,107,515) previous return: The amount by which the block Nil scheme has been increased since the date of the last return: Number of securities issued/ allotted under scheme during period: 292,388 Ordinary Shares (Loan Notes to the value of GBP73,097) Balance under scheme not yet issued /allotted at end of period 8,137,672 Ordinary Shares (Loan Notes to the value of GBP2,034,418) Number 17,092,476 Ordinary Shares (Loan and class of securities originally Notes to the value of GBP4,273,119) listed and the date of admission admitted on 8 February 2005 Total number of securities in issue 342,159,034 Ordinary Shares at the end of the period / Ends / For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com